Skip to main content
SpringerLink
Log in

Ganglion Cell Diseases

  • Chapter
  • First Online:
Inherited Chorioretinal Dystrophies

  • 1646 Accesses

Abstract

Inherited optic neuropathies are diseases of retinal ganglion cell dysfunction or loss which lead to optic atrophy. This group of conditions share many common clinical features, which comprise bilateral, symmetrical, painless reduced visual acuity; colour vision defects; central or centro-caecal visual field loss; and pallor of the optic disc. They are a genetically heterogeneous group of conditions, with autosomal dominant, recessive and X-linked, as well as mitochondrial inheritance. The dominant and mitochondrial forms are the commonest. Table 48.1 shows the seven mapped autosomal loci and five known genes to date. OPA1 is the locus for the so-called Kjer autosomal dominant optic atrophy on chromosome 3q29 (OPA1; MIM: 165500) and is due to mutation in the OPA1 gene. It is also associated with the allelic condition syndromic dominant optic atrophy, DOA + syndrome. X-linked optic atrophy 2, OPA2 (311050), has been mapped to chromosome Xp11.4-p11.21. Optic atrophy 3, or dominant optic atrophy and cataract (OPA3; 165300), is caused by mutation in the OPA3 gene (606580) on chromosome 19q13.2-q13.3. This is allelic to recessive optic atrophy 3 or Costeff syndrome. Optic atrophy 4 (OPA4; 605293) has been mapped to chromosome 18q12.2-q12.3 and optic atrophy 5 (OPA5; 610708) to chromosome 22q12.1-q13.1. Recessive optic atrophy 6 (OPA6; 258500) maps to chromosome 8q. And recessive optic atrophy 7 (OPA7; 612989) is caused by mutation in the TMEM126A gene (612988) on chromosome 11q14.1-q21. Wolfram syndrome 1 (DIDMOAD) is due to mutations in the Wolframin gene, whereas WFS2 is caused by mutation of the CSID2 gene. From this description it is clear that there remain a number of as yet unidentified genes. In addition to the above autosomal optic neuropathies, there is the maternally inherited mitochondrial disease Leber’s hereditary optic neuropathy (LHON), which is due to a primary mutation in the mitochondrial DNA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Batten B. A family suffering from hereditary optic atrophy. Trans Ophthalmol Soc UK. 1896;16:125.

    Google Scholar 

  2. Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Scand. 1959;37 Suppl 54:1–146.

    Google Scholar 

  3. Kjer B, Eiberg H, Kjer P, et al. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand. 1996;74:3–7.

    Article  CAS  PubMed  Google Scholar 

  4. Yu-Wai-Man P, Griffiths PG, Burke A, Sellar PW, Clarke MP, Gnanaraj L, Ah-Kine D, Hudson G, Czermin B, Taylor RW, Horvath R, Chinnery PF. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology. 2010;117:1538–46.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Cohn AC, Toomes C, Potter C, Towns KV, Hewitt AW, Inglehearn CF, Craig JE, Mackey DA. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am J Ophthalmol. 2007;143:656–62.

    Article  PubMed  Google Scholar 

  6. Toomes C, Marchbank NJ, Mackey DA, Craig JE, Newbury-Ecob RA, Bennett CP, Vize CJ, Desai SP, Black GCM, Patel N, Teimory M, Markham AF, Inglehearn CF, Churchill AJ. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet. 2001;10:1369–78.

    Article  CAS  PubMed  Google Scholar 

  7. Thiselton DL, Alexander C, Taanman JW, Brooks S, Rosenberg T, Eiberg H, Andreasson S, Van Regemorter N, Munier FL, Moore AT, Bhattacharya SS, Votruba M. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest Ophthalmol Vis Sci. 2002;43:1715–24.

    PubMed  Google Scholar 

  8. Eiberg H, Kjer B, Kjer P, Rosenberg T. Dominant optic atrophy (OPA1) mapped to chromosome 3q region I. Linkage analysis. Hum Mol Genet. 1994;3:977–80.

    Article  CAS  PubMed  Google Scholar 

  9. Votruba M, Moore AT, Bhattacharya SS. Genetic refinement of dominant optic atrophy (OPA1) locus to within a 2 cM interval of chromosome 3q. J Med Genet. 1997;34:117–21.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Alexander C, Votruba M, Pesch UEA, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo-Kottler B, Auburger G, Bhattacharya SS, Wissinger B. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26:211–5.

    Article  CAS  PubMed  Google Scholar 

  11. Delettre C, Lenaers G, Griffoin J-M, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26:207–10.

    Article  CAS  PubMed  Google Scholar 

  12. Fuhrmann N, Alavi MV, Bitoun P, Woernle S, Auburger G, Leo-Kottler B, Yu-Wai-Man P, Chinnery P, Wissinger B. Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy. J Med Genet. 2009;46:136–44.

    Article  CAS  PubMed  Google Scholar 

  13. Davies VJ, Hollins AJ, Piechota MJ, Yip W, Davies JR, White KE, Nicols PP, Boulton ME, Votruba M. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet. 2007;16:1307–18.

    Article  CAS  PubMed  Google Scholar 

  14. Alavi MV, Bette S, Schimpf S, Schuettauf F, Schraermeyer U, Wehrl HF, Ruttiger L, Beck SC, Tonagel F, Pichler BJ, Knipper M, Peters T, Laufs J, Wissinger B. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain. 2007;130(Pt 4):1029–42.

    PubMed  Google Scholar 

  15. Votruba M, Fitzke FW, Holder GE, et al. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol. 1998;116:351–8.

    Article  CAS  PubMed  Google Scholar 

  16. Johnston RL, Seller MJ, Behnam JT, Burdon MA, Spalton DJ. Dominant optic atrophy: refining the clinical diagnostic criteria in light of genetic linkage studies. Ophthalmology. 1999;106:123–8.

    Article  CAS  PubMed  Google Scholar 

  17. Fournier AV, Damji KF, Epstein DL, Pollock SC. Disc excavation in dominant optic atrophy. Ophthalmology. 2001;108:1595–602.

    Article  CAS  PubMed  Google Scholar 

  18. Votruba M, Thiselton D, Bhattacharya SS. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy. Br J Ophthalmol. 2003;87:48–53.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Barboni P, Savini G, Parisi V, Carbonelli M, La Morgia C, Maresca A, Sadun F, De Negri AM, Carta A, Sadun AA, Carelli V. Retinal nerve fiber layer thickness in dominant optic atrophy. Ophthalmology. 2011;118:2076–80.

    Article  PubMed  Google Scholar 

  20. Barboni P, Carbonelli M, Savini G, Foscarini B, Parisi V, Valentino ML, Carta A, De Negri A, Sadun F, Zeviani M, Sadun AA, Schimpf S, Wissinger B, Carelli V. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size. Ophthalmology. 2010;117:1547–53.

    Article  PubMed  Google Scholar 

  21. Miyata K, Nakamura M, Kondo M, Lin J, Ueno S, Miyake Y, Terasaki H. Reduction of oscillatory potentials and photopic negative response in patients with autosomal dominant optic atrophy with OPA1 mutations. Invest Ophthalmol Vis Sci. 2007;48:820–4.

    Article  PubMed  Google Scholar 

  22. Lodi R, Tonon C, Valentino ML, Iotti S, Clementi V, Malucelli E, Barboni P, Longanesi L, Schimpf S, Wissinger B, Baruzzi A, Barbiroli B, Carelli V. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol. 2004;56:719–23.

    Article  CAS  PubMed  Google Scholar 

  23. Lodi R, Tonon C, Valentino ML, Manners D, Testa C, Malucelli E, La Morgia C, Barboni P, Carbonelli M, Schimpf S, Wissinger B, Zeviani M, Baruzzi A, Liguori R, Barbiroli B, Carelli V. Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations. Arch Neurol. 2011;68:67–73.

    PubMed  Google Scholar 

  24. Johnston PB, Gaster RN, Smith VC, Tripathi RC. A clinicopathologic study of autosomal dominant optic atrophy. Am J Ophthalmol. 1979;88:868–75.

    Article  CAS  PubMed  Google Scholar 

  25. Kjer P. Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol Scand. 1983;61:300–12.

    Article  CAS  Google Scholar 

  26. Votruba M, Leary S, Losseff N, Bhattacharya SS, Moore AT, Miller DH, Moseley IF. MRI of the intraorbital optic nerve in patients with autosomal dominant optic atrophy. Neuroradiology. 2000;42:180–3.

    Article  CAS  PubMed  Google Scholar 

  27. Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, Toscano A, Musumeci O, Valentino ML, Caporali L, Lamperti C, Tallaksen CM, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010;133:771–86.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Konigsmark BW, Knox DL, Hussels IE, Moses H. Dominant congenital deafness and progressive optic nerve atrophy. Arch Ophthalmol. 1974;91:99–103.

    Article  CAS  PubMed  Google Scholar 

  29. Amati-Bonneau P, Guichet A, Olichon A, Chevrollier A, Viala F, Miot S, Ayuso C, Odent S, Arrouet C, Verny C, Calmels M-N, Simard G, Belenguer P, Wang J, Puel J-L, Hamel C, Malthiery Y, Bonneau D, Lenaers G, Reynier P. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol. 2005;58:958–63.

    Article  CAS  PubMed  Google Scholar 

  30. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A, Campos Y, Rivera H, de la Aleja JG, Carroccia R, Iommarini L, Labauge P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain. 2008;131:338–51.

    Article  PubMed  Google Scholar 

  31. Ferraris S, Clark S, Garelli E, Davidzon G, Moore SA, Kardon RH, Bienstock RJ, Longley MJ, Mancuso M, Rios PG, Hirano M, Copeland WC, DiMauro S. Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Arch Neurol. 2008;65:125–31.

    PubMed Central  PubMed  Google Scholar 

  32. Verny C, Loiseau D, Scherer C, Lejeune P, Chevrollier A, Gueguen N, Guillet V, Dubas F, Reynier P, Amati-Bonneau P, Bonneau D. Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology. 2008;70:1152–3.

    Article  CAS  PubMed  Google Scholar 

  33. Volker-Dieben HJ, Van Lith GHM, Went LN, Klawer JW, Staal A, De Vries-de Mol EC. A family with sex linked optic atrophy (ophthalmological and neurological aspects). Doc Ophthalmol. 1974;37(2):307–26.

    Article  Google Scholar 

  34. Went LN, De Vries de Mol EC, Volker-Dieben HJ. A family with apparently sex-linked optic atrophy. J Med Genet. 1975;12:94–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Assink JJM, Tijmes NT, ten Brink JB, Oostra R-J, Riemslag FC, de Jong PTVM, Bergen AAB. A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome. Am J Hum Genet. 1997;61:934–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Katz BJ, Zhao Y, Warner JEA, Tong Z, Yang Z, Zhang K. A family with X-linked optic atrophy linked to the OPA2 locus Xp11.4-Xp11.2. Am J Med Genet. 2006;140A:2207–11.

    Article  Google Scholar 

  37. Garcin R, Raverdy P, Delthil S, Man HX, Chimenes H. Sur une affection hérédo-familiale associant cataracte, atrophie optique, signes extra-pyramidaux et certains stigmates de la maladie de Friedreich. (Sa position nosologique par rapport au syndrome de Behr, au syndrome de Marinesco-Sjogren et à la maladie de Friedreich avec signes oculaires.). Rev Neurol. 1961;104:373–9.

    CAS  PubMed  Google Scholar 

  38. Reynier P, Amati-Bonneau P, Verny C, Olichon A, Simard G, Guichet A, Bonnemains C, Malecaze F, Malinge MC, Pelletier JB, Calvas P, Dollfus H, Belenguer P, Malthiery Y, Lenaers G, Bonneau D. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet. 2004;41:e110.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Costeff H, Gadoth N, Apter N, Prialnic M, Savir H. A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia. Neurology. 1989;39:595–7.

    Article  CAS  PubMed  Google Scholar 

  40. Nystuen A, Costeff H, Elpeleg ON, Apter N, Bonne-Tamir B, Mohrenweiser H, Haider N, Stone EM, Sheffield VC. Iraqi-Jewish kindreds with optic atrophy plus (3-methylglutaconic aciduria type 3) demonstrate linkage disequilibrium with the CTG repeat in the 3-prime untranslated region of the myotonic dystrophy protein kinase gene. Hum Mol Genet. 1997;6:563–9.

    Article  CAS  PubMed  Google Scholar 

  41. Anikster Y, Kleta R, Shaag A, Gahl WA, Elpeleg O. Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet. 2001;69:1218–24.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Kleta R, Skovby F, Christensen E, Rosenberg T, Gahl WA, Anikster Y. 3-Methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings. Mol Genet Metab. 2002;76:201–6.

    Article  CAS  PubMed  Google Scholar 

  43. Ho G, Walter JH, Christodoulou J. Costeff optic atrophy syndrome: new clinical case and novel molecular findings. J Inherit Metab Dis. 2008;31 Suppl 2:S419–23.

    Article  PubMed  Google Scholar 

  44. Huizing M, Dorward H, Ly L, Klootwijk E, Kleta R, Skovby F, Pei W, Feldman B, Gahl WA, Anikster Y. OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria. Mol Genet Metab. 2010;100:149–54.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Davies VJ, Powell KA, White KE, Yip W, Hogan V, Hollins AJ, Davies JR, Piechota M, Brownstein DG, Moat SJ, Nichols PP, Wride MA, Boulton ME, Votruba M. A missense mutation in the murine Opa3 gene models human Costeff syndrome. Brain. 2008;131(Pt 2):368–80.

    Article  PubMed  Google Scholar 

  46. Powell KA, Davies JR, Taylor E, Wride MA, Votruba M. Mitochondrial localization and ocular expression of mutant Opa3 in a mouse model of 3-methylglutaconicaciduria type III. Invest Ophthalmol Vis Sci. 2011;52:4369–80.

    Article  CAS  PubMed  Google Scholar 

  47. Kerrison JB, Arnould VJ, Ferraz Sallum JM, Vagefi MR, Barmada MM, Li Y, Zhu D, Maumenee IH. Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12.2-12.3. Arch Ophthalmol. 1999;117:805–10.

    Article  CAS  PubMed  Google Scholar 

  48. Barbet F, Hakiki S, Orssaud C, Gerber S, Perrault I, Hanein S, Ducroq D, Dufier J-L, Munnich A, Kaplan J, Rozet J-M. A third locus for dominant optic atrophy on chromosome 22q. J Med Genet (Lett). 2005;42:e1, Note.

    Article  CAS  Google Scholar 

  49. Barbet F, Gerber S, Hakiki S, Perrault I, Hanein S, Ducroq D, Tanguy G, Dufier J-L, Munnich A, Rozet J-M, Kaplan J. A first locus for isolated autosomal recessive optic atrophy (ROA1) maps to chromosome 8q. Eur J Hum Genet. 2003;11:966–71.

    Article  CAS  PubMed  Google Scholar 

  50. Hanein S, Perrault I, Roche O, Gerber S, Khadom N, Rio M, Boddaert N, Jean-Pierre M, Brahimi N, Serre V, Chretien D, Delphin N, Fares-Taie L, Lachheb S, Rotig A, Meire F, Munnich A, Dufier J-L, Kaplan J, Rozet J-M. TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy. Am J Hum Genet. 2009;84:493–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Huoponen K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics. 2001;3:119–25.

    Article  CAS  PubMed  Google Scholar 

  52. Barboni P, Savini G, Valentino ML, Montagna P, Cortelli P, De Negri AM, Sadun F, Bianchi S, Longanesi L, Zanini M, de Vivo A, Carelli V. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber’s hereditary optic neuropathy. Ophthalmology. 2005;112:120–6.

    Article  PubMed  Google Scholar 

  53. Ventura DF, Gualtieri M, Oliveira AGF, Costa MF, Quiros P, Sadun F, de Negri AM, Salomao SR, Berezovsky A, Sherman J, Sadun AA, Carelli V. Male prevalence of acquired color vision defects in asymptomatic carriers of Leber’s hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2007;48:2362–70.

    Article  PubMed  Google Scholar 

  54. Mann ES, Handler SP, Chung SM. Leber’s hereditary optic neuropathy masquerading as retinal vasculitis. Arch Ophthalmol. 2000;118:1587–9.

    CAS  PubMed  Google Scholar 

  55. Newman NJ. Leber’s hereditary optic neuropathy. New genetic considerations. Arch Neurol. 1993;50:540–8.

    Article  CAS  PubMed  Google Scholar 

  56. Sadun F, De Negri AM, Carelli V, Salomao SR, Berezovsky A, Andrade R, Moraes M, Passos A, Belfort R, Da Rosa AB, Quiros P, Sadun AA. Ophthalmologic findings in a large pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2004;137:271–7.

    Article  PubMed  Google Scholar 

  57. Sadun AA, Win PH, Ross-Cisneros FN, Walker SO, Carelli V. Leber’s hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc. 2000;98:223–35.

    PubMed Central  CAS  PubMed  Google Scholar 

  58. Collier DA, Barrett TG, Curtis D, Macleod A, Arranz MJ, Maassen JA, Bundey S. Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity. Am J Hum Genet. 1996;59:855–63.

    PubMed Central  CAS  PubMed  Google Scholar 

  59. El-Shanti H, Lidral AC, Jarrah N, Druhan L, Ajlouni K. Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q. Am J Hum Genet. 2000;66:1229–36.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Rotig A, Cormier V, Chatelain P, Francois R, Saudubray J-M, Rustin P, Munnich A. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy and deafness (DIDMOAD, Wolfram syndrome). J Inherit Metab Dis. 1993;16:527–30.

    Article  CAS  PubMed  Google Scholar 

  61. Hofmann S, Bezold R, Jaksch M, Obermaier-Kusser B, Mertens S, Kaufhold P, Rabl W, Hecker W, Gerbitz K-D. Wolfram (DIDMAOD) syndrome and Leber hereditary optic neuropathy (LHON) are associated with distinct mitochondrial DNA haplotypes. Genomics. 1997;39:8–18.

    Article  CAS  PubMed  Google Scholar 

  62. Strom TM, Hortnagel K, Hofmann S, Gekeler F, Scharfe C, Rabl W, Gerbitz KD, Meitinger T. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet. 1998;7:2021–8.

    Article  CAS  PubMed  Google Scholar 

  63. Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E, Meuckler M, Marshall H, Donis-Keller H, Crock P, Rogers D, Mikuni M, Kumashiro H, Higashi K, Sobue G, Oka Y, Permutt MA. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet. 1998;20:143–8.

    Article  CAS  PubMed  Google Scholar 

  64. Khanim F, Kirk J, Latif F, Barrett TG. WFS1/Wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat. 2001;17:357–67.

    Article  CAS  PubMed  Google Scholar 

  65. Chaussenot A, Bannwarth S, Rouzier C, Vialettes B, Mkadem SA, Chabrol B, Cano A, Labauge P, Paquis-Flucklinger V. Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Ann Neurol. 2011;69:501–8.

    Article  CAS  PubMed  Google Scholar 

  66. Eiberg H, Hansen L, Kjer B, Hansen T, Pedersen O, Bille M, Rosenberg T, Tranebjaerg L. Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene. J Med Genet. 2006;43:435–40.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  67. Takeda K, Inoue K, Tanizawa Y, Matsuzaki Y, Oba J, Watanabe Y, Shinoda K, Oka Y. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet. 2001;10:477–84.

    Article  CAS  PubMed  Google Scholar 

  68. Amr S, Heisey C, Zhang M, Xia X-J, Shows KH, Ajlouni K, Pandya A, Satin LS, El-Shanti H, Shiang R. A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. Am J Hum Genet. 2007;81:673–83.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  69. Swift RG, Polymeropoulos MH, Torres R, Swift M. Predisposition of Wolfram syndrome heterozygotes to psychiatric illness. Mol Psychiat. 1998;3:86–91.

    Article  CAS  Google Scholar 

  70. Sam W, Qin H, Crawford B, Yue D, Yu S. Homozygosity for a 4-bp deletion in a patient with Wolfram syndrome suggesting possible phenotype and genotype correlation. Clin Genet (Lett). 2001;59:136–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Visual Neuroscience and Molecular Biology Group, School of Optometry and Vision Sciences, Cardiff University, Maindy Road, Cardiff, CF24 4LU, UK

    Marcela Votruba

Authors
  1. Marcela Votruba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcela Votruba .

Editor information

Editors and Affiliations

  1. Service d’Exploration de la Vision et Neuro-ophtalmologie, Centre Hospitalier Universitaire de Lille, Hôpital Roger Salengro, Lille Cedex, France

    Bernard Puech

  2. Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium

    Jean-Jacques De Laey

  3. Department of Electrophysiology, Moorfields Eye Hospital, London, United Kingdom

    Graham E. Holder

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Votruba, M. (2014). Ganglion Cell Diseases. In: Puech, B., De Laey, JJ., Holder, G. (eds) Inherited Chorioretinal Dystrophies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69466-3_48

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69466-3_48

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69464-9

  • Online ISBN: 978-3-540-69466-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation